Categories
AF ablation Atrial fibrillation

More notes from the first day of the Boston AF symposium

 The second half of the day was fast paced and full of information. Folks, these are rough notes. Hope they help…Again my random thoughts are in italics.  Dr Eric Prystowsky led off the with the best clinical papers of 2011: He is a great speaker and hit upon a bunch of important topics.  The good […]

Categories
AF ablation Atrial fibrillation

The most complicated disease…AF

You may have heard that AF is a tough disease to understand. Questions far outnumber answers. What causes AF? Why do some not feel it at all, while others are incapacitated? What’s the best treatment? Drugs? Ablation? Surgery? No treatment? Should I take a blood thinner…and which one? Where should one go for the best […]

Categories
AF ablation Atrial fibrillation Dabigatran/Rivaroxaban/Apixaban

My most recent AF presentation at Norton Stroke Sympsoium

Here is the pdf version: 2011 AF and Stroke Talk (Norton) And the power point version: 2011 AF and Stroke Talk (Norton) Overview: —We will start with the accepted evidence base for warfarin. —Then move to dispel four myths about using blood-thinners in AF: Myth 1: Rhythm-control strategies prevent stroke. Myth 2: Running the INR […]

Categories
Atrial fibrillation Dabigatran/Rivaroxaban/Apixaban

Let there be three…

You can mark August 2011 as an amazing month for news in the treatment of atrial fibrillation (AF). In this post, I will attempt to share what I have learned about the two new blood-thinning drugs, apixaban and rivaroxaban–both Factor Xa inhibitors. (Disclaimer: this is not a book chapter, rather a blog post from a […]

Categories
Atrial fibrillation

Breaking news in AF treatment

Good Sunday morning friends. Yesterday brought the news of yet another important breakthrough in the treatment of AF. Apixaban, another non-warfarin blood-thinner, the third all told, was found to be both superior to warfarin in preventing strokes, associated with less bleeding and had no significant side effects. There’s a lot of data to digest. I’m […]

Categories
Atrial fibrillation Dabigatran/Rivaroxaban/Apixaban General Cardiology

The new blood thinners and personal accountability

I recently came across a very important blog post on the use of the novel new blood-thinner, dabigatran (Pradaxa). Fellow Kentucky cardiologist, and frequent TheHeart.org contributor, Dr. Melissa Walton-Shirley wrote this very detailed case presentation involving a cantankerous non-compliant rural patient with AF (atrial fibrillation) that sustained a stroke while “taking” dabigatran. Dr. Walton-Shirley details […]

Categories
Atrial fibrillation Dabigatran/Rivaroxaban/Apixaban General Medicine

Rivaroxaban: The next non-warfarin oral blood thinner

The unrelenting epidemic of inactivity and excessive eating wreaks havoc on more than just the heart and blood vessels. Lugging around extra weight also breaks down the joints and back. For evidence, look no further than the waiting room of any orthopedist; the people waiting for joint replacements look the same as those waiting to […]

Categories
Atrial fibrillation Dabigatran/Rivaroxaban/Apixaban

An update on AF: New blood thinners

It’s been awhile since I have written about the treatment of atrial fibrillation (AF). I would like to remedy this by sharing a few thoughts on three recent stories about AF: one involved a soon-to-be-approved blood-thinning drug; the second highlighted a potentially exciting new device for ablating AF, and the third story irresponsibly sensationalized the […]

Categories
Atrial fibrillation

Warfarin-replacement parade gets crowded

The dabigatran party isn’t even cleaned-up yet, when another warfarin competitor has hit the press wires. As reported on Cardiobrief from a Bayer press release, Rivaroxaban (Xarelto) was as effective as warfarin in stroke prevention in patients’ with AF. A composite of major and minor bleeding events were also similar to warfarin. Rivaroxaban is a […]